Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism.
D'Agostino C, Zonzin P, Enea I, Gulizia MM, Ageno W, Agostoni P, Azzarito M, Becattini C, Bongarzoni A, Bux F, Casazza F, Corrieri N, D'Alto M, D'Amato N, D'Armini AM, De Natale MG, Di Minno G, Favretto G, Filippi L, Grazioli V, Palareti G, Pesavento R, Roncon L, Scelsi L, Tufano A. D'Agostino C, et al. Eur Heart J Suppl. 2017 May;19(Suppl D):D309-D332. doi: 10.1093/eurheartj/sux030. Epub 2017 May 2. Eur Heart J Suppl. 2017. PMID: 28751848 Free PMC article.
Androgen Receptor Supports an Anchorage-Independent, Cancer Stem Cell-like Population in Triple-Negative Breast Cancer.
Barton VN, Christenson JL, Gordon MA, Greene LI, Rogers TJ, Butterfield K, Babbs B, Spoelstra NS, D'Amato NC, Elias A, Richer JK. Barton VN, et al. Cancer Res. 2017 Jul 1;77(13):3455-3466. doi: 10.1158/0008-5472.CAN-16-3240. Epub 2017 May 16. Cancer Res. 2017. PMID: 28512248 Free PMC article.
Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer.
Gordon MA, D'Amato NC, Gu H, Babbs B, Wulfkuhle J, Petricoin EF, Gallagher I, Dong T, Torkko K, Liu B, Elias A, Richer JK. Gordon MA, et al. Mol Cancer Ther. 2017 Jul;16(7):1389-1400. doi: 10.1158/1535-7163.MCT-17-0111. Epub 2017 May 3. Mol Cancer Ther. 2017. PMID: 28468774 Free PMC article.
[The APULIA HF multicenter study: efficacy of a management protocol shared between hospital and territorial health services for acute decompensated heart failure patients].
Iacoviello M, Pede S, Aspromonte N, Bux F, Panunzio M, Donadeo V, De Castro A, Antoncecchi E, D'Amato N, Squiccimarro E, Silvestri B, Malerba L, De Gennaro L, Modugno G, Serafini E, Curci B, Grande D, Colivicchi F, De Luca G, Ignone G, D'Agostino C, Caldarola P. Iacoviello M, et al. G Ital Cardiol (Rome). 2017 Feb;18(2):150-158. doi: 10.1714/2663.27300. G Ital Cardiol (Rome). 2017. PMID: 28398368 Italian.
[ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism].
D'Agostino C, Zonzin P, Enea I, Gulizia MM, Ageno W, Agostoni P, Azzarito M, Becattini C, Bongarzoni A, Bux F, Casazza F, Corrieri N, D'Alto M, D'Amato N, D'Armini AM, De Natale MG, Di Minno G, Favretto G, Filippi L, Grazioli V, Palareti G, Pesavento R, Roncon L, Scelsi L, Tufano A. D'Agostino C, et al. G Ital Cardiol (Rome). 2016 Sep;17(9 Suppl 1):68S-109. doi: 10.1714/2450.25670. G Ital Cardiol (Rome). 2016. PMID: 27869893 Italian.
Cooperative Dynamics of AR and ER Activity in Breast Cancer.
D'Amato NC, Gordon MA, Babbs B, Spoelstra NS, Carson Butterfield KT, Torkko KC, Phan VT, Barton VN, Rogers TJ, Sartorius CA, Elias A, Gertz J, Jacobsen BM, Richer JK. D'Amato NC, et al. Mol Cancer Res. 2016 Nov;14(11):1054-1067. doi: 10.1158/1541-7786.MCR-16-0167. Epub 2016 Aug 26. Mol Cancer Res. 2016. PMID: 27565181 Free PMC article.
A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
D'Amato NC, Rogers TJ, Gordon MA, Greene LI, Cochrane DR, Spoelstra NS, Nemkov TG, D'Alessandro A, Hansen KC, Richer JK. D'Amato NC, et al. Cancer Res. 2015 Nov 1;75(21):4651-64. doi: 10.1158/0008-5472.CAN-15-2011. Epub 2015 Sep 11. Cancer Res. 2015. PMID: 26363006 Free PMC article.
Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.
Barton VN, D'Amato NC, Gordon MA, Christenson JL, Elias A, Richer JK. Barton VN, et al. Horm Cancer. 2015 Dec;6(5-6):206-13. doi: 10.1007/s12672-015-0232-3. Epub 2015 Jul 23. Horm Cancer. 2015. PMID: 26201402 Free PMC article. Review.
Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivo.
Barton VN, D'Amato NC, Gordon MA, Lind HT, Spoelstra NS, Babbs BL, Heinz RE, Elias A, Jedlicka P, Jacobsen BM, Richer JK. Barton VN, et al. Mol Cancer Ther. 2015 Mar;14(3):769-78. doi: 10.1158/1535-7163.MCT-14-0926. Epub 2015 Feb 23. Mol Cancer Ther. 2015. PMID: 25713333 Free PMC article.
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.
Cochrane DR, Bernales S, Jacobsen BM, Cittelly DM, Howe EN, D'Amato NC, Spoelstra NS, Edgerton SM, Jean A, Guerrero J, Gómez F, Medicherla S, Alfaro IE, McCullagh E, Jedlicka P, Torkko KC, Thor AD, Elias AD, Protter AA, Richer JK. Cochrane DR, et al. Breast Cancer Res. 2014 Jan 22;16(1):R7. doi: 10.1186/bcr3599. Breast Cancer Res. 2014. PMID: 24451109 Free PMC article.
49 results
Jump to page
Feedback